TilbroquinolCAS# 7175-09-9 |
- MGCD-265
Catalog No.:BCC2479
CAS No.:875337-44-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 7175-09-9 | SDF | Download SDF |
PubChem ID | 65592 | Appearance | Powder |
Formula | C10H8BrNO | M.Wt | 238.08 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : ≥ 50 mg/mL (210.01 mM) H2O : < 0.1 mg/mL (insoluble) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 7-bromo-5-methylquinolin-8-ol | ||
SMILES | CC1=CC(=C(C2=C1C=CC=N2)O)Br | ||
Standard InChIKey | JMOVFFLYGIQXMM-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C10H8BrNO/c1-6-5-8(11)10(13)9-7(6)3-2-4-12-9/h2-5,13H,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Tilbroquinol Dilution Calculator
Tilbroquinol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.2003 mL | 21.0013 mL | 42.0027 mL | 84.0054 mL | 105.0067 mL |
5 mM | 0.8401 mL | 4.2003 mL | 8.4005 mL | 16.8011 mL | 21.0013 mL |
10 mM | 0.42 mL | 2.1001 mL | 4.2003 mL | 8.4005 mL | 10.5007 mL |
50 mM | 0.084 mL | 0.42 mL | 0.8401 mL | 1.6801 mL | 2.1001 mL |
100 mM | 0.042 mL | 0.21 mL | 0.42 mL | 0.8401 mL | 1.0501 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Tilbroquinol is an antiprotozoal agent effective against amoebiasis. It has also been used against Vibrio cholerae.
- Vasicine Hydrochloride
Catalog No.:BCC8265
CAS No.:7174-27-8
- Chilenine
Catalog No.:BCN7799
CAS No.:71700-15-7
- Amisulpride
Catalog No.:BCC4459
CAS No.:71675-85-9
- H-His-NH2.2HCl
Catalog No.:BCC2955
CAS No.:71666-95-0
- Cephalomannine
Catalog No.:BCN5343
CAS No.:71610-00-9
- Biphenyl-3-carboxylic acid
Catalog No.:BCC8878
CAS No.:716-76-7
- D-(-)-threo-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
Catalog No.:BCC8924
CAS No.:716-61-0
- 3alpha,6beta-Ditigloyloxytropan-7beta-ol
Catalog No.:BCN1370
CAS No.:7159-86-6
- NSC 319726
Catalog No.:BCC2242
CAS No.:71555-25-4
- Safrolglycol
Catalog No.:BCN4596
CAS No.:7154-01-0
- AC480 (BMS-599626)
Catalog No.:BCC1252
CAS No.:714971-09-2
- Vinorelbine
Catalog No.:BCN2543
CAS No.:71486-22-1
- Avermectin B1
Catalog No.:BCC1381
CAS No.:71751-41-2
- Ampicillin Trihydrate
Catalog No.:BCC8820
CAS No.:7177-48-2
- Nafcillin Sodium
Catalog No.:BCC4805
CAS No.:7177-50-6
- Clazamycin B
Catalog No.:BCN1961
CAS No.:71774-49-7
- Vidofludimus
Catalog No.:BCC5387
CAS No.:717824-30-1
- Verbenacine
Catalog No.:BCN6473
CAS No.:717901-03-6
- PF-431396
Catalog No.:BCC3971
CAS No.:717906-29-1
- PF-562271
Catalog No.:BCC3674
CAS No.:717907-75-0
- Lys-[Des-Arg9]Bradykinin
Catalog No.:BCC5991
CAS No.:71800-36-7
- Clazamycin A
Catalog No.:BCN1960
CAS No.:71806-55-8
- H-D-Ala-NH2.HCl
Catalog No.:BCC3197
CAS No.:71810-97-4
- Z-Thr-ol
Catalog No.:BCC2574
CAS No.:71811-27-3
[In vitro sensitivity of Vibrio cholerae serotype 0:139 to an intestinal antiseptic tiliquinol-tilbroquinol combination].[Pubmed:8003903]
Bull Soc Pathol Exot. 1994;87(1):38-40.
O:139 is a new serotype of Vibrio cholerae that is not agglutinated by an O:1 antiserum but causes epidemics of cholera. Strains of O:139 serotype are resistant to O/129 compound and many antibiotics but are sensitive to tetracyclines and tiliquinol-Tilbroquinol (Intetrix). The clinical management of the patients infected with serotype O:139 is identical to that of usual choleric patients. However, the immunological difference with O:1 serotype must lead to reconsider both the diagnosis and the vaccinating strategies of cholera.